|
1.
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
2.
|
Pitson SM: Regulation of sphingosine
kinase and sphingolipid signaling. Trends Biochem Sci. 36:97–107.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Gamble JR, Sun WY, Li X, Hahn CN, Pitson
SM, Vadas MA and Bonder CS: Sphingosine kinase-1 associates with
integrin {alpha}V{beta}3 to mediate endothelial cell survival. Am J
Pathol. 175:2217–2225. 2009.PubMed/NCBI
|
|
4.
|
Bergelin N, Blom T, Heikkilä J, et al:
Sphingosine kinase as an oncogene: autocrine sphingosine
1-phosphate modulates ML-1 thyroid carcinoma cell migration by a
mechanism dependent on protein kinase C-alpha and ERK1/2.
Endocrinology. 150:2055–2063. 2009. View Article : Google Scholar
|
|
5.
|
Li W, Yu CP, Xia JT, et al: Sphingosine
kinase 1 is associated with gastric cancer progression and poor
survival of patients. Clin Cancer Res. 15:1393–1399. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Pchejetski D, Doumerc N, Golzio M, et al:
Chemosensitizing effects of sphingosine kinase-1 inhibition in
prostate cancer cell and animal models. Mol Cancer Ther.
7:1836–1845. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kawamori T, Kaneshiro T, Okumura M, et al:
Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J.
23:405–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Nemoto S, Nakamura M, Osawa Y, et al:
Sphingosine kinase isoforms regulate oxaliplatin sensitivity of
human colon cancer cells through ceramide accumulation and Akt
activation. J Biol Chem. 284:10422–10432. 2009. View Article : Google Scholar
|
|
9.
|
Wang H, Maurer BJ, Liu YY, et al:
N-(4-Hydroxyphenyl) retinamide increases dihydroceramide and
synergizes with dimethylsphingosine to enhance cancer cell killing.
Mol Cancer Ther. 7:2967–2976. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Kohno M, Momoi M, Oo ML, et al:
Intracellular role for sphingosine kinase 1 in intestinal adenoma
cell proliferation. Mol Cell Biol. 26:7211–7223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Schwock J, Dhani N and Hedley DW:
Targeting focal adhesion kinase signaling in tumor growth and
metastasis. Expert Opin Ther Targets. 14:77–94. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Hao HF, Naomoto Y, Bao XH, et al: Progress
in researches about focal adhesion kinase in gastrointestinal
tract. World J Gastroenterol. 15:5916–5923. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Leve F, Marcondes TG, Bastos LG, Rabello
SV, Tanaka MN and Morgado-Díaz JA: Lysophosphatidic acid induces a
migratory phenotype through a crosstalk between RhoA-Rock and
Src-FAK signalling in colon cancer cells. Eur J Pharmacol.
671:7–17. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Dia VP and Gonzalez de Mejia E: Lunasin
potentiates the effect of oxaliplatin preventing outgrowth of colon
cancer metastasis, binds to α5β1 integrin and suppresses
FAK/ERK/NF-κB signaling. Cancer Lett. 313:167–180. 2011.PubMed/NCBI
|
|
15.
|
Zhao J, Singleton PA, Brown ME, Dudek SM
and Garcia JG: Phosphotyrosine protein dynamics in cell membrane
rafts of sphingosine-1-phosphate-stimulated human endothelium: role
in barrier enhancement. Cell Signal. 21:1945–1960. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Lee OH, Lee DJ, Kim YM, Kim YS, Kwon HJ,
Kim KW and Kwon YG: Sphingosine 1-phosphate stimulates tyrosine
phosphorylation of focal adhesion kinase and chemotactic motility
of endothelial cells via the G(i) protein-linked phospholipase C
pathway. Biochem Biophys Res Commun. 268:47–53. 2000. View Article : Google Scholar
|
|
17.
|
Gibbs TC, Rubio MV, Zhang Z, Xie Y, Kipp
KR and Meier KE: Signal transduction responses to lysophosphatidic
acid and sphingosine 1-phosphate in human prostate cancer cells.
Prostate. 69:1493–1506. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Pettus BJ, Bielawski J, Porcelli AM, et
al: The sphingosine kinase 1/sphingosine-1-phosphate pathway
mediates COX-2 induction and PGE2 production in response to
TNF-alpha. FASEB J. 17:1411–1421. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Cuvillier O, Ader I, Bouquerel P, Brizuela
L, Malavaud B, Mazerolles C and Rischmann P: Activation of
sphingosine kinase-1 in cancer: implications for therapeutic
targeting. Curr Mol Pharmacol. 3:53–65. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Nagahashi M, Ramachandran S, Kim EY, et
al: Sphingosine-1-phosphate produced by sphingosine kinase 1
promotes breast cancer progression by stimulating angiogenesis and
lymphangiogenesis. Cancer Res. 72:726–735. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Maceyka M, Harikumar KB, Milstien S and
Spiegel S: Sphingosine-1-phosphate signaling and its role in
disease. Trends Cell Biol. 22:50–60. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Hao H, Naomoto Y, Bao X, Watanabe N, et
al: Focal adhesion kinase as potential target for cancer therapy
(Review). Oncol Rep. 22:973–979. 2009.PubMed/NCBI
|
|
23.
|
Lechertier T and Hodivala-Dilke K: Focal
adhesion kinase and tumour angiogenesis. J Pathol. 226:404–412.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Stokes JB, Adair SJ, Slack-Davis JK, et
al: Inhibition of focal adhesion kinase by PF-562,271 inhibits the
growth and metastasis of pancreatic cancer concomitant with
altering the tumor microenvironment. Mol Cancer Ther. 10:2135–2145.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Yu HG, Tong SL, Ding YM, et al: Enhanced
expression of cholecystokinin-2 receptor promotes the progression
of colon cancer through activation of focal adhesion kinase. Int J
Cancer. 119:2724–2732. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Kobayashi H, Boelte KC and Lin PC:
Endothelial cell adhesion molecules and cancer progression. Curr
Med Chem. 14:377–386. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Shah N, Cabanillas F, McIntyre B, Feng L,
et al: Prognostic value of serum CD44, intercellular adhesion
molecule-1 and vascular cell adhesion molecule-1 levels in patients
with indolent non-Hodgkin lymphomas. Leuk Lymphoma. 53:50–56. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Lu X, Mu E, Wei Y, Riethdorf S, et al:
VCAM-1 promotes osteolytic expansion of indolent bone
micrometastasis of breast cancer by engaging α4β1-positive
osteoclast progenitors. Cancer Cell. 20:701–714. 2011.PubMed/NCBI
|
|
29.
|
Dymicka-Piekarska V, Guzinska-Ustymowicz
K, Kuklinski A and Kemona H: Prognostic significance of adhesion
molecules (sICAM-1, sVCAM-1) and VEGF in colorectal cancer
patients. Thromb Res. 129:e47–e50. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Alexiou D, Karayiannakis AJ, Syrigos KN,
Zbar A, Kremmyda A, Bramis I and Tsigris C: Serum levels of
E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients:
correlations with clinicopathological features, patient survival
and tumour surgery. Eur J Cancer. 37:2392–2397. 2001. View Article : Google Scholar
|
|
31.
|
Kase H, Hattori Y, Jojima T, et al:
Globular adiponectin induces adhesion molecule expression through
the sphingosine kinase pathway in vascular endothelial cells. Life
Sci. 81:939–943. 2007. View Article : Google Scholar
|
|
32.
|
Fong YC, Lin CY, Su YC, et al: CCN6
enhances ICAM-1 expression and cell motility in human
chondrosarcoma cells. J Cell Physiol. 227:223–232. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Petzold T, Orr AW, Hahn C, Jhaveri KA,
Parsons JT and Schwartz MA: Focal adhesion kinase modulates
activation of NF-kappaB by flow in endothelial cells. Am J Physiol
Cell Physiol. 297:C814–C822. 2009. View Article : Google Scholar
|
|
34.
|
Taglia L, Matusiak D, Matkowskyj KA and
Benya RV: Gastrin-releasing peptide mediates its morphogenic
properties in human colon cancer by upregulating intracellular
adhesion protein-1 (ICAM-1) via focal adhesion kinase. Am J Physiol
Gastrointest Liver Physiol. 292:G182–G190. 2007. View Article : Google Scholar
|
